جدول الترويج Longboard Pharmaceuticals, Inc.
الجدول الزمني المتقدم
رسم بياني بسيط
عن الشركة
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. Its lead product candidate is LP352, which is in Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. The company's preclinical product candidate includes LP659 which focuses on developing therapies for multiple neurological diseases; and LP143. It also entered into license agreement with Arena Pharmaceuticals Inc. مزيد من التفاصيلEBITDA | -0.0144 |
---|---|
EV/EBITDA | 3.84 |
IPO date | 2021-03-12 |
ISIN | US54300N1037 |
Industry | Biotechnology |
P/BV | 0.8062 |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.longboardpharma.com |
Цена ао | 58.86 |
Число акций ао | 0.02273 млрд |
تغير السعر يوميا: | 0% (59.08) |
---|---|
تغير السعر في الأسبوع: | +77.1% (33.36) |
تغير السعر شهريا: | +72.14% (34.32) |
تغير السعر خلال 3 أشهر: | +64.11% (36) |
تغير السعر على مدى ستة أشهر: | +238.76% (17.44) |
تغير السعر سنويا: | +1 115.64% (4.86) |
تغير السعر على مدى 3 سنوات: | +551.38% (9.07) |
تغير الأسعار منذ بداية العام: | +980.07% (5.47) |
|
الاستهانة
|
كفاءة
|
|||||||||||||||||||||||||||||||||||||
توزيعات الأرباح
|
واجب
|
دافع النمو
|
المؤسسات | مقدار | يشارك, % |
---|---|---|
Cormorant Asset Management, LP | 2353141 | 7 |
FMR, LLC | 1649503 | 4.91 |
Price (T.Rowe) Associates Inc | 1626982 | 4.84 |
Farallon Capital Management Llc | 1560500 | 4.64 |
Polar Capital Holdings PLC | 1000000 | 2.98 |
Ikarian Capital, LLC | 979462 | 2.91 |
Integral Health Asset Management, LLC | 900000 | 2.68 |
Blackrock Inc. | 869879 | 2.59 |
Point72 Asset Management, L.P. | 825000 | 2.45 |
Vanguard Group Inc | 786433 | 2.34 |
ETF | يشارك, % | الربحية لهذا العام, % | توزيعات الأرباح, % |
---|---|---|---|
Avantis U.S Small Cap Equity ETF | 0.01814 | 27.774101036841 | 1.68271 |
Avantis U.S. Equity ETF | 0.00066 | 30.338089728757 | 1.59151 |
Virtus LifeSci Biotech Clinical Trials ETF | 1.3448 | 63.040315712071 | 0.33 |
iShares ESG Aware MSCI USA Small-Cap ETF | 0.04743 | 29.190260475651 | 1.49366 |
Fidelity MSCI Health Care Index ETF | 0.01532 | 11.599806669889 | 1.46057 |
ProShares Hedge Replication ETF | 0.0058 | 5.9237999659878 | 1.47892 |
Humankind US Stock ETF | 0.00353 | 18.809430395549 | 1.99919 |
iShares Neuroscience and Healthcare ETF | 2.11526 | 19.720292847757 | 0.03 |
iShares Morningstar Small-Cap ETF | 0.01851 | 30.095066471445 | 1.60498 |
iShares Morningstar Small-Cap Growth ETF | 0.01676 | 33.628071953382 | 0.72598 |
iShares Morningstar Small Cap Value ETF | 0.02069 | 26.701717953559 | 2.50476 |
iShares Micro-Cap ETF | 0.27803 | 29.340359461748 | 1.54048 |
iShares Russell 2000 Growth ETF | 0.08101 | 38.042556988 | 0.6026 |
iShares Russell 3000 ETF | 0.00126 | 30.952834139099 | 1.43482 |
iShares Morningstar Small-Cap ETF | 0.01851 | 391.25300933451 | 1.60498 |
iShares Morningstar Small-Cap Growth ETF | 0.01676 | 680.05582339508 | 0.72598 |
iShares Morningstar Small-Cap Value ETF | 0.02069 | 213.164717614 | 2.50476 |
Nuveen ESG Small-Cap ETF | 0.09807 | 25.458025704129 | 1.41019 |
Direxion Daily Pharmaceutical & Medical Bull 3X Shares | 1.2465 | 86.715867158672 | 1.2989 |
ProShares UltraPro Russell2000 | 0.02367 | 89.821266282945 | 1.47873 |
Vanguard U.S. Momentum Factor ETF | 0.18 | 45.845704753962 | 1.05834 |
Vanguard Russell 3000 ETF | 0 | 31.87314172448 | 1.43817 |
Vanguard Russell 2000 Growth ETF | 0.09 | 35.148104265403 | 0.60264 |
Vanguard Russell 2000 ETF | 0.04 | 30.781541744465 | 1.48801 |
SPDR S&P Pharmaceuticals ETF | 2.34795 | 29.798803697662 | 1.29889 |
مشرف | مسمى وظيفي | قسط | سنة الميلاد |
---|---|---|---|
Mr. Kevin R. Lind | President, CEO, Secretary & Director | 1.07M | 1976 (48 سنين) |
Ms. Brandi L. Roberts CPA, M.B.A. | Executive VP & CFO | 662.65k | 1974 (50 سنين) |
Dr. Randall E. Kaye M.D. | Executive VP & Chief Medical Officer | 717.95k | 1962 (62 سنة) |
Mr. Chadwick J. Orevillo MPH | Executive VP & Head of Operations | N/A | |
Mr. Steven W. Spector J.D. | Executive VP, Head of Business Development & General Counsel | N/A | 1965 (59 سنين) |
Dr. Anne M. Danks Ph.D. | VP & Head of Nonclinical Research & Development | N/A | |
Mr. Gus Cardenas | VP & Head of Quality Assurance | N/A | |
Dr. Marco Peters Ph.D. | VP & Head of Translational Science | N/A | |
Dr. Dewey McLin Ph.D. | VP & Head of Medical Affairs | N/A | |
Ms. Megan E. Knight | VP & Head of Investor Relations |
عنوان: United States, La Jolla. CA, 4275 Executive Square - مفتوحة في خرائط جوجل, فتح خرائط ياندكس
موقع إلكتروني: https://www.longboardpharma.com
موقع إلكتروني: https://www.longboardpharma.com